CureVac N.V. (BIT:1CVAC)

CureVac Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	392.7	481.75	402.45	495.8	811.46	1,323
Cash & Short-Term Investments	392.7	481.75	402.45	495.8	811.46	1,323
Cash Growth	93.91%	19.70%	-18.83%	-38.90%	-38.65%	4014.84%
Accounts Receivable	0.41	16.84	17.08	9	18.5	1.82
Other Receivables	7.29	16.04	22.43	32.99	37.95	10.42
Receivables	7.7	32.88	39.51	41.99	56.45	12.25
Inventory	0.54	0.54	24.8	23.99	56.16	14.53
Prepaid Expenses	14.22	0.79	1.08	9.85	14.01	40.05
Other Current Assets	4.61	10.45	10.54	12.4	1.94	0.43
Total Current Assets	419.78	526.41	478.38	584.03	940.02	1,390
Property, Plant & Equipment	238.41	244.65	278.63	241.7	200.39	100.59
Goodwill	-	12.46	12.46	12.46	-	-
Other Intangible Assets	25.07	12.69	15.88	19.3	12.27	13.46
Long-Term Deferred Tax Assets	4.11	5.09	1.19	1.3	2.86	0.45
Long-Term Deferred Charges	-	-	-	-	0.52	1.03
Other Long-Term Assets	1.51	1.51	1.7	1.68	2.18	5.98
Total Assets	688.88	802.83	788.25	860.47	1,158	1,511
Accounts Payable	7.58	17.27	48.03	-	122.26	17.62
Accrued Expenses	-	11.13	10.54	78.29	9.36	19.19
Current Portion of Leases	4.89	5.32	5.01	4.98	3.47	3.23
Current Income Taxes Payable	18.25	18.25	0.65	0.61	0.74	0.39
Current Unearned Revenue	-	-	44.58	36.78	58.92	194.05
Other Current Liabilities	37.3	20.38	77.57	35.56	162.99	13.14
Total Current Liabilities	68.02	72.35	186.39	156.23	357.73	247.62
Long-Term Debt	-	-	-	-	-	25.19
Long-Term Leases	31.15	33.64	36.82	37.11	25.42	26.85
Long-Term Unearned Revenue	0.17	-	48.1	72.55	86.35	500.06
Long-Term Deferred Tax Liabilities	0.23	0.23	-	-	-	-
Other Long-Term Liabilities	2.95	-	-	61.34	0.26	0.28
Total Liabilities	102.51	106.22	271.31	327.22	469.77	800.01
Common Stock	27.02	26.92	26.88	23.4	22.45	21.66
Retained Earnings	-1,515	-1,404	-1,566	-1,306	-1,057	-645.07
Treasury Stock	-	-	-	-1.48	-5.82	-
Comprehensive Income & Other	2,075	2,073	2,056	1,817	1,729	1,335
Shareholders' Equity	586.37	696.61	516.94	533.25	688.48	711.35
Total Liabilities & Equity	688.88	802.83	788.25	860.47	1,158	1,511
Total Debt	36.03	38.97	41.82	42.09	28.89	55.28
Net Cash (Debt)	356.67	442.78	360.63	453.71	782.57	1,267
Net Cash Growth	118.17%	22.78%	-20.52%	-42.02%	-38.25%	-
Net Cash Per Share	1.59	1.97	1.63	2.40	4.21	9.59
Filing Date Shares Outstanding	229.08	225.16	223.99	194.95	187.03	180.46
Total Common Shares Outstanding	229.08	224.34	223.99	194.95	187.12	180.46
Working Capital	351.76	454.07	291.99	427.8	582.29	1,142
Book Value Per Share	2.56	3.11	2.31	2.74	3.68	3.94
Tangible Book Value	561.3	671.45	488.59	501.49	676.2	697.89
Tangible Book Value Per Share	2.45	2.99	2.18	2.57	3.61	3.87
Buildings	-	28.2	27.54	26.47	27.27	19.95
Machinery	-	71.64	67.68	62.59	63.47	31.63
Construction In Progress	-	183.65	178.99	138.46	124.54	39.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.